Single‐cell RNA sequencing (scRNA‐seq) offers powerful cellular‐resolution insights into tumour heterogeneity, enabling the identification of rare but clinically relevant subpopulations such as MHC‐deficient tumour cells or exhausted T cells. This evidence concerns the gene HLA-C and neoplasm.